Climara and Sandostatin lar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Climara and Sandostatin lar. Common interactions include abdominal distension among females.

The phase IV clinical study analyzes what interactions people who take Climara and Sandostatin lar have. It is created by eHealthMe based on reports of 14 people who take Climara and Sandostatin lar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 24, 2023

14 people who take Climara and Sandostatin lar together, and have interactions are studied.


What is Climara?

Climara has active ingredients of estradiol. It is often used in menopause. eHealthMe is studying from 6,489 Climara users for its effectiveness, alternative drugs and more.

What is Sandostatin lar?

Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 35,253 Sandostatin lar users for its effectiveness, alternative drugs and more.

Number of Climara and Sandostatin lar reports submitted per year:

Climara and Sandostatin lar drug interactions.

Common Climara and Sandostatin Lar drug interactions by gender *:

female:

  1. Abdominal distension
  2. Abdominal pain
  3. Fatigue
  4. Hot flush
  5. Musculoskeletal pain
  6. Nausea
  7. Productive cough
  8. Pruritus
  9. Renal impairment
  10. Rhinorrhoea

male:

n/a

Common Climara and Sandostatin Lar drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Arrhythmia
  2. Blood pressure increased
  3. Bronchitis
  4. Death
  5. Hypoaesthesia
  6. Nephrolithiasis
  7. Pleural mesothelioma
  8. Raynaud's phenomenon
  9. Second primary malignancy

60+:

  1. Abdominal distension
  2. Abdominal pain
  3. Fatigue
  4. Hot flush
  5. Musculoskeletal pain
  6. Nausea
  7. Productive cough
  8. Pruritus
  9. Renal impairment
  10. Rhinorrhoea

Common conditions people have *:

  1. Carcinoid Tumor: 11 people, 78.57%
  2. Pain In Extremity: 10 people, 71.43%
  3. Back Pain: 8 people, 57.14%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 57.14%
  5. Pancreatic Carcinoma (pancreatic cancer): 1 person, 7.14%
  6. Neuroendocrine Carcinoma Metastatic (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems and spreads to other part): 1 person, 7.14%
  7. High Blood Pressure: 1 person, 7.14%
  8. Bone Disorder: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Climara and Sandostatin lar?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Climara and Sandostatin lar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Climara side effects:

Browse all side effects of Climara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sandostatin lar side effects:

Browse all side effects of Sandostatin lar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Climara interactions:

Browse all interactions between Climara and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sandostatin lar interactions:

Browse all interactions between Sandostatin lar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on estradiol and octreotide acetate (the active ingredients of Climara and Sandostatin lar, respectively), and Climara and Sandostatin lar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Climara and Sandostatin lar.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: